KDM6A and myeloid sarcoma: Similarly, in the widely used autoimmune encephalomyelitis, MS mouse model, knockout of KDM6A limited the development of the autoimmune disease by suppressing CD44 expression on CD4+ T cells via H3K27me3 targeting Th2 cytokines expression and Th1 response blockade [65].